Clik here to view.
Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan...
CHENGDU, China Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that it has initiated...
View ArticleClik here to view.
Sengenics, a Leading Precision Medicine Focused Company, to Present at the...
SINGAPORE Sengenics, a leading precision medicine focused company, today announced that Dr Arif Anwar, CEO of Sengenics, will present a company overview at the 2020 BIO CEO and Investor Conference....
View ArticleClik here to view.
IDT Offers Preferred Pricing and Early Access to Complete Portfolio of...
CORALVILLE, Iowa Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced that it is accepting pre-orders from the global public health and research...
View ArticleClik here to view.
インサイト、ルキソリチニブ・クリームのTRuE-AD2ピボタル試験がアトピー性皮膚炎の患者で主要評価項目を達成したと発表
米デラウェア州ウィルミントン （ビジネスワイヤ） — インサイト（Nasdaq:INCY）は本日、ランダム化・溶媒対照・ピボタル第3相TRuE-AD2試験の良好なトップライン結果を発表しました。TRuE-AD2試験はアトピー性皮膚炎を患う青年・成人患者（12歳以上）でルキソリチニブ・クリームの安全性と有効性を評価するものです。...
View ArticleClik here to view.
First Dosing in Exopharm’s PLEXOVAL Exosome Wound Healing Human Study
MELBOURNE, Australia Regenerative medicine company Exopharm Limited (ASX:EX1) announces first dosing has occurred in the PLEXOVAL Phase I study using exosomes isolated from human platelets for wound...
View ArticleClik here to view.
AgeX Therapeutics Enters Research Collaboration With Japanese Biopharma...
ALAMEDA, Calif. AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today a research collaboration with...
View ArticleClik here to view.
BIONIK Laboratories Announces Regulatory Approval and First Sale of its...
TORONTO & BOSTON BIONIK Laboratories Corp. (OTCQB:BNKL) (“BIONIK”), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and...
View ArticleClik here to view.
Genetron Health to Participate in China National Key Research and Development...
BEIJING Genetron Health, a China-based precision oncology company that provides full cycle cancer management solutions, announced it was selected to participate in 2019 China National Key Research...
View ArticleClik here to view.
CORRECTING and REPLACING IDT Offers Preferred Pricing and Early Access to...
CORALVILLE, Iowa Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: IDT OFFERS PREFERRED PRICING AND EARLY ACCESS TO COMPLETE...
View ArticleClik here to view.
希少疾患のCDKL5欠損症にWHOの疾病分類コードが付与される
ロンドン （ビジネスワイヤ） — 希少遺伝性疾患のCDKL5欠損症（CDD）が、世界保健機関（WHO）の医学的分類リストである国際疾病分類（ICD）で新しい疾病コードを割り当てられました。CDKL5欠損症の診断コードは、2020年10月1日のICD改訂版に盛り込まれます。...
View ArticleClik here to view.
Amazentis在达沃斯世界经济论坛上宣布推出Timeline™细胞营养
瑞士达沃斯 (美国商业资讯)–瑞士食品和营养谷(Swiss Food & Nutrition Valley)的成员Amazentis在瑞士达沃斯世界经济论坛瑞士馆宣布推出旨在促进健康衰老的下一代营养产品Timeline。鉴于全球老龄人口的增长——据2019年德意志银行的研究，地球上65岁以上人士首次超过5岁以下的人口——消费者必须采取积极措施来维持其有生之年的高品质生活。...
View ArticleClik here to view.
罕见病CDKL5缺乏障碍列入世界卫生组织疾病分类
伦敦 (美国商业资讯)–世界卫生组织(WHO)医学分类列表国际疾病分类(ICD)已为罕见的基因疾病CDKL5缺乏障碍(CDD)指定了新的疾病编码。CDKL5缺乏障碍诊断编码将列入2020年10月1日的分类修订版。...
View ArticleClik here to view.
Co-Diagnostics, Inc. Announces Successful Initial Verification of Novel...
SALT LAKE CITY Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today the successful initial...
View ArticleClik here to view.
AntiCancer Inc. to Target Its Oral Recombinant Methioninase Against 2019-nCoV...
SAN DIEGO Currently there are no therapies or vaccines for patients infected with 2019-nCoV coronavirus around the world. As the number of 2019-nCoV patients approaches 10,000 and more than 200...
View ArticleClik here to view.
Merz Aesthetics在2020年IMCAS世界大会上呈报数据
德国法兰克福 (美国商业资讯)–全球美容医学领导者Merz今天宣布，将在2020年英卡思国际整形美容暨皮肤抗衰老大师课程(IMCAS)世界大会上通过口述呈报和壁报介绍Merz Aesthetics产品阵容的数据，包括Belotero®、Cellfina®和Radiesse®，此次大会将于2020年1月30日至2月1日在法国巴黎召开。 Merz Aesthetics首席执行官Bob...
View ArticleClik here to view.
メルツ・エステティックスが2020年IMCAS国際会議でデータを発表
独フランクフルト （ビジネスワイヤ） — 医療美容の世界的リーダー企業であるメルツは本日、Belotero®、Cellfina®、Radiesse®を含むメルツ・エステティックスの製品ポートフォリオに関するデータが、2020年1月30日～2月1日にフランスのパリで開催される2020年加齢科学国際マスター・コース（IMCAS）国際会議の口頭発表とポスター発表で取り上げられると発表されました。...
View ArticleClik here to view.
Ligand’s Technologies Support and Enable Potential Coronavirus Treatments
SAN DIEGO Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that its proprietary technologies are being utilized by partners to support and enable potential treatments for the 2019 novel...
View ArticleClik here to view.
Alpha Holdings Urges OncoSec Stockholders to Vote Against China Grand...
SEONGNAM, South Korea Alpha Holdings, Inc. (KOSDAQ: 117670) (“Alpha”), the largest stockholder of OncoSec Medical Incorporated (NASDAQ: ONCS) (“OncoSec”), with an approximate 15.1% ownership stake,...
View ArticleClik here to view.
Takeda Demonstrates Business Momentum, Accelerated Integration Synergies, and...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502)(NYSE:TAK): This press release features multimedia. View the full release here:...
View ArticleClik here to view.
武田薬品：良好なビジネスモメンタムおよび統合シナジーの加速化により、2019 年度通期業績予想は財務ベース営業利益の黒字転換を含む上方修正
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 (東証:4502) (NYSE:TAK)： 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：https://www.businesswire.com/news/home/20200203005853/ja/ 2019 年度第 3...
View Article